RxDoctor Payments Data

Ben Odell, MD

Internal Medicine · Ashland, KYNPI 1770677734

Payments from drug & device makers

$1,901in general payments, 2019–2025

Across 126 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$426
  • AbbVie$347
  • Lilly USA, LLC$169
  • Pfizer$142
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$125
  • Bayer$115
  • plus $578 from 18 others

What the payments were for

  • Food & beverage$1,88999%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,901 in reported general payments places this provider in the 75th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$109,898
Medicare patients
348
Services billed
1,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$93,794
OzempicSemaglutide70$90,117
JardianceEmpagliflozin90$77,131
TrulicityDulaglutide46$67,045
MounjaroTirzepatide54$66,096
XifaxanRifaximin15$60,706
JanuviaSitagliptin Phosphate40$55,516
XareltoRivaroxaban21$19,962
JanumetSitagliptin Phos/Metformin Hcl14$19,410
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog29$15,475
Lantus SolostarInsulin Glargine,hum.Rec.Anlog73$13,857
Spiriva HandihalerTiotropium Bromide19$13,612
InvokanaCanagliflozin16$13,281
Breo ElliptaFluticasone/Vilanterol21$10,512
Tresiba Flextouch U-100Insulin Degludec11$9,702

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$169$133,140100 claims
PfizerEliquis$142$93,79479 claims
Novo NordiskOzempic$80$90,11770 claims
MerckJanuvia, Janumet$13$74,92654 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$125$60,70615 claims
GSKBreo Ellipta$14$10,51221 claims
AstraZenecaSymbicort$44$2,66912 claims
AbbVieSynthroid$347$2,47070 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,284 internal medicine providers in Kentucky.

Other internal medicine in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →